// App-Quantinova.ai

242 : Maternal Red Blood Cell Alloimmunization Managed with Intrauterine Blood Transfusion: Predictors of Poor Outcome

Researchers

Presenter

  • Evangelia Vlachodimtropoulou Koumoutsea

Principal Investigators

  • Maciej W. Garbowski

  • Tim VanMieghem

  • Shelley Solomon

  • Nimrah Abbasi

  • Gareth Seaward

  • Rory Windrim

  • Johannes Keunen

  • Edmond Kelly

  • Nadine Shehata

  • Greg Ryan

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • Fetal Medicine Unit MSH and Ontario Fetal Centre, london, Canada

  • Transfusion Laboratory, Mount Sinai Hospital, Toronto, Canada

  • Mount Sinai Hospital, Fetal Medicine, Toronto, ON, Canada

  • University of Toronto, Fetal Medicine Unit MSH and Ontario Fetal Centre, Toronto, ON, Canada

  • University of Toronto, Fetal Medicine Unit MSH and Ontario Fetal Centre, Toronto, ON, Canada

  • Fetal Medicine Unit MSH and Ontario Fetal Centre, london, Canada

  • Hosp Sick Children, Toronto, Canada

  • Department of Laboratory Medicine and Pathology, Mount Sinai Hospital, Toronto, ON, Canada

  • University of Toronto, Fetal Medicine Unit MSH and Ontario Fetal Centre, Toronto, ON, Canada

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

  • IVIG

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved